Skip to Main Content

Author Details

Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1991
93
48
PMIDPaper TitleJournal TitlePublished Year
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
31493539Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.Biol Blood Marrow Transplant2020
31493539Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.Biol Blood Marrow Transplant2020
31089138miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8<sup>+</sup> T cell fate.Nat Commun2019
31089138miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8<sup>+</sup> T cell fate.Nat Commun2019
31258878High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.J Extracell Vesicles2019
30778251The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity.Nat Immunol2019
31258878High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.J Extracell Vesicles2019
30778251The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity.Nat Immunol2019
28614804In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease.JCI Insight2017
28614804In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease.JCI Insight2017
26704363HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cells.Int J Cancer2016
26934227NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Nature2016
27045023Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization.Cancer Immunol Res2016
27129922Distinct IL-7 signaling in recent thymic emigrants versus mature naïve T cells controls T-cell homeostasis.Eur J Immunol2016
26704363HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cells.Int J Cancer2016
27999744Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs.Oncoimmunology2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27999744Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs.Oncoimmunology2016
27129922Distinct IL-7 signaling in recent thymic emigrants versus mature naïve T cells controls T-cell homeostasis.Eur J Immunol2016
27045023Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization.Cancer Immunol Res2016
26934227NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.Nature2016
25616156Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.Eur J Immunol2015
25616156Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.Eur J Immunol2015
26942073CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.Oncoimmunology2015
27730151Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models.ERJ Open Res2015
27730151Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models.ERJ Open Res2015
26942073CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.Oncoimmunology2015
24919573Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.Clin Cancer Res2014
25323160Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.Respiration2014
24810640Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.J Immunother2014
24810636IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.Eur J Immunol2014
24919573Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.Clin Cancer Res2014
24778279Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Cancer Immunol Res2014
25323160Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.Respiration2014
24810640Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.J Immunother2014
24810636IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.Eur J Immunol2014
24778279Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Cancer Immunol Res2014
23271806Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery.Proc Natl Acad Sci U S A2013
23955711Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.Nat Med2013
23796475Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.J Hepatol2013
23481183Using macrophage activation to augment immunotherapy of established tumours.Br J Cancer2013
23271806Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery.Proc Natl Acad Sci U S A2013
23541182Sensitive GC-MS/MS method to measure deuterium labeled deoxyadenosine in DNA from limited mouse cell populations.Anal Chem2013
23955711Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.Nat Med2013
23796475Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.J Hepatol2013
23481183Using macrophage activation to augment immunotherapy of established tumours.Br J Cancer2013
23541182Sensitive GC-MS/MS method to measure deuterium labeled deoxyadenosine in DNA from limited mouse cell populations.Anal Chem2013
  • 1 - 50 of 186

Recommended Authors

Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 5
Donghui Cheng
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 11
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Frank C Marini
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 6
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 2
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 2
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 1
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0
James M Reuben
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 0
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 1
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 19

Collaborators

William G Telford
National Cancer Institute, National Institutes of Health
Co-authored papers 20
Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers 11
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 8
Subramani Mani
Co-authored papers 6
Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 4
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Xiao-Yi Yan
Liaoning Normal University
Co-authored papers 3
Masaki Terabe
National Cancer Institute
Co-authored papers 3
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 2
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Co-authored papers 2
Daniel F Heitjan
Co-authored papers 2
Najibah Rehman
Cincinnati Children's Hospital Medical Center
Co-authored papers 2
Jeremy J Rose
National Cancer Institute
Co-authored papers 2
Frances T Hakim
National Cancer Institute
Co-authored papers 2
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers 1
Bernd Heinrich
Clinic for Gastroenterology, Hannover Medical School
Co-authored papers 1
Joshua A Welsh
Co-authored papers 1
Huan Wang
Clinical Center, National Institutes of Health
Co-authored papers 1
Lars Zender
Co-authored papers 1
Jacqueline W Mays
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 1
Noam A Cohen
Co-authored papers 1
Michelle Dyke
Co-authored papers 1
Daniel W McVicar
National Cancer Institute
Co-authored papers 1
Jennifer C Jones
Co-authored papers 1
Wei Zhu
Georgia Cancer Center, Medical College of Georgia
Co-authored papers 1
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 1
Renae Judy
Co-authored papers 1
Release 1.2